Analytica Limited broadens Enhanced Infusion System into Middle-East

KUALA LUMPUR, April 28 -- Analytica Limited has entered into an agreement with Marwa’s Office for Export & Import Medical Supplies (Marwa) to distribute, market and sell the Enhanced Infusion System (EIS) to hospital systems.

According to a statement, the agreement involves hospitals in Egypt, Bahrain, Iran, Iraq, Jordan, Kuwait, Lebanon, Saudi Arabia and the United Arab Emirates.

Analytica is the Australian developer of the EIS and PeriCoach® pelvic floor exercise system for the treatment of stress urinary incontinence.

The EIS technology was developed under the project names AutoStart and AutoFlush and has been sold in Australia with the trade name FirstFlow™, under limited licence.

EIS combines the AutoStart and AutoFlush patented technologies into a simple and inexpensive solution.

The patented float system automatically restarts IV fluid flow following medication delivery, thereby saving healthcare workers’ time, reducing hospital costs and preventing the adverse events associated with air embolism and failure of Peripheral Intravenous Catheters.

The EIS reacts immediately, silently and without intervention or programming. 

It can be retrofitted to any existing infusion system design and work in harmony with and improve the capability of any infusion pump or ‘bag’ infusion system, regardless of sophistication.

Use of the EIS uniquely allows a completely closed infusion system, with integrity achieved by reducing the interactions believed to cause mechanical and vascular complications as well as good flushing and/or patency practice.

The EIS is compact, rugged and does not require a pump or energy source, which makes it suitable for retrieval, military and third world needs without compromising risk.

-- BERNAMA